Key result
A De Ritis ratio ≥1.19 on admission was significantly associated with an INR ≥4 in the initial 10 days of warfarin therapy among patients undergoing heart valve replacement surgery.
Why the study?
Does a De Ritis ratio ≥1.19 on admission predict an INR ≥4 in the initial 10 days of warfarin therapy in patients who underwent heart valve replacement surgery?
Does a De Ritis ratio ≥1.19 on admission predict an INR ≥4 in the initial 10 days of warfarin therapy in patients who underwent heart valve replacement surgery?
Answers are grounded in this paper and cite their sources.
A De Ritis ratio ≥1.19 on admission may serve as a useful prognostic marker to identify patients at risk of over-anticoagulation early in warfarin therapy following heart valve replacement.
A De Ritis ratio ≥1.19 on admission was significantly associated with an INR ≥4 in the initial 10 days of warfarin therapy among patients underwent heart valve replacement surgery.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2019) studied this question. A De Ritis ratio ≥1.19 on admission was significantly associated with an INR ≥4 in the initial 10 days of warfarin therapy among patients undergoing heart valve replacement surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: